Next Generation Sequencers Market Size, Share, Opportunities, And Trends By Offering (Product, Services), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others), By Application (Diagnostics, Drug Discovery, Biomarker Discovery, Agriculture & Animal Research, Others), By End-User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, Others), And By Geography – Forecasts From 2025 To 2030

Next Generation Sequencers Market Size:

The next-generation sequencers market is expected to grow at a CAGR of 7.35% during the projected period from 2025 to 2030.

Next-generation sequencing (NGS) is a massively parallel sequencing technology that enables scalability, ultra-high throughput, and quick speed. It can be used to establish the order of the nucleotides in the complete genome. DNA pre-sequencing is one of the most crucial steps in the entire sequencing methodology, which involves preparing the material for the following sequencing reaction. Globally, NGS is being gradually included in clinical laboratory analysis, testing, and illness diagnosis. Pharmacogenomics has made extensive efforts to speed up the drug discovery process. Genome mapping programs, next-generation sequencing applications, healthcare spending, and technology improvements are the main factors driving the next-generation sequencers market growth during the projected period.

What are the Next Generation Sequencers Market Drivers?

• Increasing use in diagnosis is anticipated to raise the demand for next-generation sequencers globally.

Next-generation sequencing market is increasing as the nucleotides in the entire genome can be determined using NGS. As it includes preparing the material for the following sequencing reaction, DNA pre-sequencing is one of the most important processes in the sequencing protocol. Globally, NGS is being gradually included in medical laboratory analysis, evaluation, and illness diagnosis. Pharmacogenomics has extensively used NGS to speed up the drug discovery process. 

The rising key development and innovations by the market players in advancing diagnosis are expected to promote the market's overall expansion in the coming years. For instance, in March 2023, SOPHiA GENETICS collaborated with Qiagen to improve tumor analysis using NGS. The agreement paired QIAseq reagent technology with the DDM platform. Customers will be able to obtain QIAseq panels processed by SOPHiA DDM™, a cloud-based platform that analyses data from diverse sources to enable completely new research perspectives, thanks to the agreement. The partnership will initially support homologous recombination repair (HRR), a unique biomarker test to find tumors with specific mutations that may make them vulnerable to PARP inhibitors in oncology, using QIAseq Targeted DNA Pro panels for somatic variant detection.

• The growing use of sequencing by synthesis will boost the next-generation sequencers market expansion.

A significant portion of the sequencing by synthesis technology system can be attributed to the growing accessibility of NGS systems built on this technology.

The ion semiconductor sequencing, on the other hand, is anticipated to expand quickly throughout the projected period. Ion semiconductor sequencing equipment is more sophisticated and affordable than other DNA sequencing techniques, impacting sector growth. Thus, the broad range of applications for the ion semiconductor sequencing technique will fuel the development of the NGS industry. For instance, Next-generation sequencing technology developed by Illumina, known as sequencing by synthesis, is widely used worldwide. Massively parallel sequencing is supported by Illumina sequencing equipment and supplies utilizing a unique technique that recognizes single bases as they are inserted into developing DNA strands.

• Rising demand for targeted re-sequencing is anticipated to promote the market growth for next-generation sequencers.

One of the main factors influencing segmental growth is the rising use of targeted re-sequencing in oncology research. As it can aid researchers in efficiently and successfully analyzing the cancer genome, targeted re-sequencing is being utilized more frequently to examine the cancer genome. In the upcoming years, this trend is anticipated to persist and foster segmental expansion. The segment's growth rate is also accelerated by an expanding number of technological breakthroughs in targeted re-sequencing and its growing use in clinical applications, further promoting the next-generation sequencers market share.

What are the Next Generation Sequencers Market Restraints?

• Data storage and management issues could restrain next-generation sequencers’ market growth.

The next-generation sequencers’ market size is hampered due to the vast amount of data created by next-generation sequencing, as well as its administration and interpretation. NGS still presents great obstacles in data storage, processing, quality control management, and interpretation, slowing the transition from the bench to the bedside despite enormous advances in expanding NGS applications from research to clinic. The market expansion of next-generation sequencing is also constrained by the absence of built-in infrastructure for next-generation sequencing because it is an advanced technology that requires significant startup expenses and expert labor, making it expensive to invest.

Next Generation Sequencers Market Geographical Outlook:

• The Next Generation Sequencers Market is segmented into five regions worldwide

Geography-wise, the next-generation sequencers market is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. North America is anticipated to be a significant next-generation sequencers marketplace globally. The next-generation sequencer market is anticipated to be dominated by North America, and this trend is anticipated to last for several more years. The use of NGS technology in routine clinical diagnostic tests is growing in popularity. This industry’s growth is expected to be boosted by elements including the rising prevalence of infectious and chronic diseases, rising genomics spending, and rising advances by major industry competitors. For instance, the Canadian Cancer Society predicts that in 2024, 6,600 Canadians will be diagnosed with leukemia. Further, the US Department of Health and Human Services reported 62,770 new cases in 2024, accounting for 3.1% of all new cancer cases. This will contribute to the demand for innovative solutions for the detection and diagnosis of this condition, leading to market growth during the projected period.

Next Generation Sequencers Market Key Developments: 

• In October 2024, Illumina, a global leader in DNA sequencing and array-based technologies, introduced the MiSeq i100 Series, offering unparalleled benchtop speed and simplicity for NGS in labs.
•  In April 2024, NewBiologix launched its next-generation sequencing and optical mapping platform, a suite of technologies designed to provide comprehensive genomic analysis services to the biopharmaceutical industry, aiming to address gaps in gene therapy manufacturing and drive the next wave of biopharmaceutical discoveries.

The Next Generation Sequencers Market is segmented and analyzed as follows:

• By Offering
  • Product
  • Services
• By Technology
  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
  • Others
• By Application
  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Agriculture & Animal Research
  • Others
• By End-User
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Institutes
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

Our Best-Performing Industry Reports:

• Medical Devices Packaging Market
• Medical Holography Market
• Smart Medical Device Market

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. NEXT GENERATION SEQUENCERS MARKET BY OFFERING

5.1. Introduction

5.2. Product

5.3. Services

6. NEXT GENERATION SEQUENCERS MARKET BY TECHNOLOGY

6.1. Introduction

6.2. Sequencing By Synthesis

6.3. Ion Semiconductor Sequencing

6.4. Single-molecule Real-time Sequencing

6.5. Nanopore Sequencing

6.6. Others

7. NEXT GENERATION SEQUENCERS MARKET BY APPLICATION

7.1. Introduction

7.2. Diagnostics

7.3. Drug Discovery

7.4. Biomarker Discovery

7.5. Agriculture & Animal Research

7.6. Others

8. NEXT GENERATION SEQUENCERS MARKET BY END-USER

8.1. Introduction

8.2. Hospitals & Clinics

8.3. Pharmaceutical & Biotechnology Companies

8.4. Academics & Research Institutes

8.5. Others

9. NEXT GENERATION SEQUENCERS MARKET BY GEOGRAPHY

9.1. Global Overview

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia-Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Quest Diagnostics Incorporated

11.2. ARUP Laboratories

11.3. Applied Biological Materials, Inc. (ABM)

11.4. Novogene Co., Ltd.

11.5. Azenta Life Sciences (GENEWIZ)

11.6. NanoString

11.7. Illumina, Inc.

11.8. PacBio

11.9. Qiagen

11.10. Thermo Fisher Scientific

LIST OF FIGURES

LIST OF TABLES

Quest Diagnostics Incorporated

ARUP Laboratories

Applied Biological Materials, Inc. (ABM)

Novogene Co., Ltd.

Azenta Life Sciences (GENEWIZ)

NanoString

Illumina, Inc.

PacBio

Qiagen

Thermo Fisher Scientific